US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Qudian Inc.

2.97

-0.0200-0.67%

Post-market: 2.970.00000.00%16:04 EDT

Volume:135.77K

Turnover:402.38K

Market Cap:490.43M

PE:12.02

High:3.00

Open:2.98

Low:2.94

Close:2.99

Loading ...

Overview Company News Filings

Qudian Inc. Reports Strong Q1 2025 Turnaround

Qudian Q1 Adj. EPS $0.12, Sales $3.55M, Company Exits Quarter With Cash & Equivalents Worth $664.607M

Qudian Inc. Reports Q1 2025 Results: Revenue Drops to RMB25.8M, Net Income Swings to RMB150.1M, EPS at RMB0.87

Qudian Q1 Income From Operations RMB -65.474 Million

THOMSON REUTERS

Qudian Inc. Reports First Quarter 2025 Unaudited Financial Results

THOMSON REUTERS

Mineralys Therapeutics Announces Late-Breaking Presentation of Data from the Launch-HTN Pivotal Trial of Lorundrostat in Uncontrolled or Resistant Hypertension at 34th European Meeting on Hypertension and Cardiovascular Protection (ESH 2025)

QD Laser, Inc. Reports Growth and Leadership Transition

Asian Equities Traded in the US as American Depositary Receipts Lower in Friday Trading, Ends Week Up Slightly

MT Newswires Live

QD Laser FY Parent Loss Y445.00M Vs Loss Y642.00M

Incyte Reports 2025 First Quarter Financial Results and Provides Updates on Key Clinical Programs

Why Is Cancer Drug Developer Revolution Medicines Stock Trading Higher On Monday?

Discovering US Undiscovered Gems In April 2025

Simply Wall St.

Qudian Full Year 2024 Earnings: EPS: CN¥0.50 (vs CN¥0.18 in FY 2023)

Simply Wall St.

Arcus Biosciences to Present First Combination Data for HIF-2a Inhibitor Casdatifan Plus Cabozantinib in an Oral Presentation at the 2025 ASCO Annual Meeting

Qudian Files Its Annual Report on Form 20-F

Mineralys Therapeutics Announces Late-Breaking Data from Advance-HTN Pivotal Trial of Lorundrostat in Uncontrolled and Resistant Hypertension Presented at the American College of Cardiology’s Annual Scientific Session & Expo (ACC.25)

Press Release: Tyra Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights

Press Release: InnoCare Releases 2024 Results and Business Highlights

New study results reinforce TAGRISSO® (osimertinib) as the backbone therapy for EGFR-mutated lung cancer across stages and settings

Qudian Inc. Reports Strong 2024 Revenue Growth

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/QD/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"QD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"QD\",,,,,undefined,":{"symbol":"QD","market":"US","secType":"STK","nameCN":"Qudian Inc.","latestPrice":2.97,"timestamp":1749240000000,"preClose":2.99,"halted":0,"volume":135771,"hourTrading":{"tag":"盘后","latestPrice":2.97,"preClose":2.97,"latestTime":"16:04 EDT","volume":2,"amount":5.94,"timestamp":1749240258609},"delay":0,"floatShares":121000000,"shares":165126492,"eps":0.247018,"marketStatus":"Post-Mkt","change":-0.02,"latestTime":"06-06 16:19:15 EDT","open":2.98,"high":2.995,"low":2.94,"amount":402375.5658,"amplitude":0.018395,"askPrice":3.25,"askSize":100,"bidPrice":2.68,"bidSize":100,"shortable":3,"etf":0,"ttmEps":0.247018,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1749254400000},"marketStatusCode":4,"adr":1,"adrRate":1,"listingDate":1508299200000,"exchange":"NYSE","adjPreClose":2.99,"postHourTrading":{"tag":"盘后","latestPrice":2.97,"preClose":2.97,"latestTime":"16:04 EDT","volume":2,"amount":5.94,"timestamp":1749240258609},"volumeRatio":0.839545,"impliedVol":0.9848,"impliedVolPercentile":0.836},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"QD\",,,,,undefined,":{"symbol":"QD","floatShares":121000000,"roa":"-1.57%","roe":"2.77%","lyrEps":0.068728,"volumeRatio":0.839545,"shares":165126492,"dividePrice":0,"high":2.995,"amplitude":0.018395,"preClose":2.99,"low":2.94,"week52Low":1.52,"pbRate":"0.31","psRate":"18.92","week52High":3.34,"institutionHeld":0,"latestPrice":2.97,"eps":0.247018,"divideRate":0,"volume":135771,"delay":0,"ttmEps":0.247018,"open":2.98,"prevYearClose":2.82,"prevWeekClose":2.96,"prevMonthClose":2.96,"prevQuarterClose":2.69,"fiveDayClose":2.96,"twentyDayClose":2.89,"sixtyDayClose":2.7},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"QD\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2540746572","title":"Qudian Inc. Reports Strong Q1 2025 Turnaround","url":"https://stock-news.laohu8.com/highlight/detail?id=2540746572","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540746572?lang=en_us&edition=fundamental","pubTime":"2025-06-03 11:54","pubTimestamp":1748922888,"startTime":"0","endTime":"0","summary":"Qudian Inc. ( ($QD) ) has released its Q1 earnings. Here is a breakdown of the information Qudian Inc. presented to its investors. Qudian Inc. is a...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/qudian-inc-reports-strong-q1-2025-turnaround?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/qudian-inc-reports-strong-q1-2025-turnaround?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4563","BK4166","BK4503","QD"],"gpt_icon":0},{"id":"2539223446","title":"Qudian Q1 Adj. EPS $0.12, Sales $3.55M, Company Exits Quarter With Cash & Equivalents Worth $664.607M","url":"https://stock-news.laohu8.com/highlight/detail?id=2539223446","media":"Benzinga","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539223446?lang=en_us&edition=fundamental","pubTime":"2025-05-30 18:07","pubTimestamp":1748599667,"startTime":"0","endTime":"0","summary":"Qudian Q1 Adj. EPS $0.12, Sales $3.55M, Company Exits Quarter With Cash & Equivalents Worth $664.607M","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/05/45689629/qudian-q1-adj-eps-0-12-sales-3-55m-company-exits-quarter-with-cash-equivalents-worth-664-607m","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QD"],"gpt_icon":0},{"id":"2539223374","title":"Qudian Inc. Reports Q1 2025 Results: Revenue Drops to RMB25.8M, Net Income Swings to RMB150.1M, EPS at RMB0.87","url":"https://stock-news.laohu8.com/highlight/detail?id=2539223374","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539223374?lang=en_us&edition=fundamental","pubTime":"2025-05-30 18:00","pubTimestamp":1748599232,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Qudian Inc. published the original content used to generate this news brief via PR Newswire  on May 30, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250530:nNDL3Z2DWj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Qudian Inc. Reports Q1 2025 Results: Revenue Drops to RMB25.8M, Net Income Swings to RMB150.1M, EPS at RMB0.87","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QD"],"gpt_icon":0},{"id":"2539223567","title":"Qudian Q1 Income From Operations RMB -65.474 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2539223567","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539223567?lang=en_us&edition=fundamental","pubTime":"2025-05-30 18:00","pubTimestamp":1748599208,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250530:nPLX9034DA:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4563","QD","BK4503","BK4166"],"gpt_icon":0},{"id":"2539235592","title":"Qudian Inc. Reports First Quarter 2025 Unaudited Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2539235592","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539235592?lang=en_us&edition=fundamental","pubTime":"2025-05-30 18:00","pubTimestamp":1748599208,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250530:nTUA75BKSW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4563","QD","BK4503","BK4166"],"gpt_icon":0},{"id":"2538110399","title":"Mineralys Therapeutics Announces Late-Breaking Presentation of Data from the Launch-HTN Pivotal Trial of Lorundrostat in Uncontrolled or Resistant Hypertension at 34th European Meeting on Hypertension and Cardiovascular Protection (ESH 2025)","url":"https://stock-news.laohu8.com/highlight/detail?id=2538110399","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538110399?lang=en_us&edition=fundamental","pubTime":"2025-05-24 16:30","pubTimestamp":1748075400,"startTime":"0","endTime":"0","summary":"– Largest hypertension trial of an aldosterone synthase inhibitor to date demonstrated the efficacy of lorundrostat in over 1,000 participants with uncontrolled or resistant hypertension in a real-wor","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/05/24/3087776/0/en/Mineralys-Therapeutics-Announces-Late-Breaking-Presentation-of-Data-from-the-Launch-HTN-Pivotal-Trial-of-Lorundrostat-in-Uncontrolled-or-Resistant-Hypertension-at-34th-European-Mee.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","CSII","BK4539","ARB","BK4166","BK4503","BK4563","BK4139","QD","BK4007","LENZ"],"gpt_icon":0},{"id":"2537986962","title":"QD Laser, Inc. Reports Growth and Leadership Transition","url":"https://stock-news.laohu8.com/highlight/detail?id=2537986962","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537986962?lang=en_us&edition=fundamental","pubTime":"2025-05-21 17:22","pubTimestamp":1747819344,"startTime":"0","endTime":"0","summary":"QD Laser, Inc. ( ($JP:6613) ) just unveiled an update. QD Laser, Inc. reported a 5% year-on-year increase in net sales for FY2024, with a reduction...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/qd-laser-inc-reports-growth-and-leadership-transition?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/qd-laser-inc-reports-growth-and-leadership-transition?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["QD","BK4166","BK4563","BK4503"],"gpt_icon":0},{"id":"2535222319","title":"Asian Equities Traded in the US as American Depositary Receipts Lower in Friday Trading, Ends Week Up Slightly","url":"https://stock-news.laohu8.com/highlight/detail?id=2535222319","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535222319?lang=en_us&edition=fundamental","pubTime":"2025-05-16 22:35","pubTimestamp":1747406103,"startTime":"0","endTime":"0","summary":"Asian equities traded in the US as American depositary receipts were slightly lower Friday morning, declining 0.26% to 2,246.05 on the S&P Asia 50 ADR Index, which is up 0.36% for the week.From North Asia, the gainers were led by video-sharing platform Bilibili  and online discount retailer Vipshop , which climbed 8% and 6.1%, respectively. They were followed by computer hardware maker Canaan  and consumer lending firm Qudian , which were up 5% and 3.9%, respectively.The decliners from North Asia were led by automotive marketplace Token Cat  and pet-focused platform Boqii , which dropped 19% and 4.1%, respectively. They were followed by financial services company CNFinance  and online fashion marketplace MOGU , which lost 5% and 2.7%, respectively.From South Asia, the lone gainer was telecommunications operator Telekomunikasi Indonesia , which rose 1.3%.The decliners from South Asia were led by IT firms Infosys  and Wipro , which fell 2.9% and 1.7%, respectively. They were followed by ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0531971678.HKD","TC","LU0536402901.SGD","LU2226246903.HKD","BK7502","LU1105468828.SGD","LU1508157978.USD","BK4577","AFG","LU2177674079.SGD","LU2265009873.SGD","BK7096","HDB","BK4523","LU0630378692.HKD","IE00B3M56506.USD","LU0333810181.USD","LU1323998911.USD","LU0164881194.USD","PHI","BILI","LU0528227936.USD","BK4513","LU1267930656.SGD","LU1805238398.USD","BQ","BK4509","CAN","QD","LU0791591158.USD","CAN.AU","BK4134","CNF","LU0898667661.SGD","MOGU","VIPS","INFY","WIT","BK4117","LU0918141705.HKD","LU0541501648.USD","LU0197773160.USD","LU0456842615.SGD","TLK","BK4170","BK4526","LU1115378108.SGD","BK4566","IE00B0JY6M65.USD","BK4115"],"gpt_icon":1},{"id":"2535105097","title":"QD Laser FY Parent Loss Y445.00M Vs Loss Y642.00M","url":"https://stock-news.laohu8.com/highlight/detail?id=2535105097","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535105097?lang=en_us&edition=fundamental","pubTime":"2025-05-14 15:30","pubTimestamp":1747207800,"startTime":"0","endTime":"0","summary":"Dividends for periods in the future are forecasts.This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4563","BK4166","BK4503","QD"],"gpt_icon":0},{"id":"2531781315","title":"Incyte Reports 2025 First Quarter Financial Results and Provides Updates on Key Clinical Programs","url":"https://stock-news.laohu8.com/highlight/detail?id=2531781315","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531781315?lang=en_us&edition=fundamental","pubTime":"2025-04-29 19:00","pubTimestamp":1745924400,"startTime":"0","endTime":"0","summary":"– Total revenues of $1,053 million in the first quarter  ; total product revenues of $922 million in Q1'25 . – Jakafi  net product revenues of $709 million in Q1'25 ; increasing full year 2025 Jakafi guidance to a new range of $2,950 - $3,000 million from $2,925 - $2,975 million. – Opzelura  cream net product revenues of $119 million in Q1'25 . – Niktimvo  net product revenues of $14 million in the first two months of U.S. launch demonstrating strong commercial execution and high patient need. – New, 18-week data from ongoing Phase 3 study of povorcitinib in hidradenitis suppurativa  demonstrates continued improvement in HiSCR from Week 12 in addition to high response rates in placebo-crossover patients. – Positive Phase 2 topline results for povorcitinib in chronic spontaneous urticaria  demonstrates proof-of-concept in new indication. WILMINGTON, Del., April 29, 2025----Incyte  today reports 2025 first quarter financial results, and provides a status update on the Company’s clinical ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/incyte-reports-2025-first-quarter-110000860.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4094","BK4590","BK4503","ET","FL","PN","BK4585","BK4581","BK4096","BK4166","BK4139","BK4563","BTC","INCY","BK4561","QD","BK4550","BK4588","BK4582","BK4532","BK4144","IAI"],"gpt_icon":0},{"id":"2530069233","title":"Why Is Cancer Drug Developer Revolution Medicines Stock Trading Higher On Monday?","url":"https://stock-news.laohu8.com/highlight/detail?id=2530069233","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530069233?lang=en_us&edition=fundamental","pubTime":"2025-04-28 23:02","pubTimestamp":1745852567,"startTime":"0","endTime":"0","summary":"\"These data reinforce the clinical potential of zoldonrasib following the initial tolerability and antitumor activity reported late last year in patients with pancreatic ductal adenocarcinoma,\" said Mark A. Goldsmith, CEO and chairman of Revolution Medicines. \"Together these results support further evaluation of zoldonrasib as monotherapy and in combination as we continue efforts to advance innovative targeted medicines for patients living with these hard-to-treat cancers,\" Goldsmith commented.RMC-9805-001 is a multicenter, open-label, dose-escalation and dose-expansion Phase 1 study designed to evaluate zoldonrasib in patients with advanced solid tumors harboring a KRAS G12D mutation.As of December 2, 2024, the data cutoff date, 90 solid tumor patients were treated with 1200 mg once daily , the candidate's recommended Phase 2 dose.In these patients, zoldonrasib demonstrated an acceptable safety profile that was generally consistent with previously reported data for this compound in pa","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/why-cancer-drug-developer-revolution-150247153.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4141","LU2357305700.SGD","LU1720051017.SGD","BK4139","LU1861215975.USD","BK4585","QD","LU2360107325.USD","IE00BZ199S13.USD","LU1978683503.SGD","LU0724618433.USD","LU1720051108.HKD","LU1548497426.USD","IE00BD6J9T35.USD","LU1854103824.USD","LU1861219969.SGD","LU0124384867.USD","BK4166","MDCO","LU2298322129.HKD","RVMDW","BK4563","BK4512","LU1854104046.USD","BK4503","ON","RVMD","LU1861220033.SGD","BK4588","BK4605","LU1861214812.USD","LU0348723411.USD"],"gpt_icon":0},{"id":"2530965468","title":"Discovering US Undiscovered Gems In April 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2530965468","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530965468?lang=en_us&edition=fundamental","pubTime":"2025-04-25 01:33","pubTimestamp":1745516009,"startTime":"0","endTime":"0","summary":"As the U.S. market experiences a surge, driven by investor reactions to earnings reports and potential tariff adjustments, small-cap stocks are gaining renewed attention amid this broader economic backdrop. With major indices like the S&P 500 and Nasdaq Composite showing significant gains, discovering lesser-known stocks that can thrive in such dynamic conditions becomes crucial for investors seeking diversification and growth potential.Top 10 Undiscovered Gems With Strong Fundamentals In The United States. Operations: Burke & Herbert Financial Services generates revenue primarily through its community banking segment, amounting to $233.03 million. The company's financial performance is reflected in its net profit margin of 24%.NasdaqCM:BHRB Earnings and Revenue Growth as at Apr 2025. Overview: Hingham Institution for Savings offers a range of financial products and services to individuals and small businesses in the United States, with a market capitalization of $536.34 million.Operat","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/discovering-us-undiscovered-gems-april-173329315.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["QD","HIFS","BHRB","BK4563","BK4166","BK4195","BK4211","BK4503"],"gpt_icon":0},{"id":"2529606767","title":"Qudian Full Year 2024 Earnings: EPS: CN¥0.50 (vs CN¥0.18 in FY 2023)","url":"https://stock-news.laohu8.com/highlight/detail?id=2529606767","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529606767?lang=en_us&edition=fundamental","pubTime":"2025-04-24 18:00","pubTimestamp":1745488806,"startTime":"0","endTime":"0","summary":"Profit margin: 42% . The increase in margin was driven by higher revenue.This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality.NYSE:QD Earnings and Revenue History April 24th 2025. All figures shown in the chart above are for the trailing 12 month  period. Qudian shares are up 6.9% from a week ago.You should always think about risks. Case in point, we've spotted   1 warning sign for Qudian  you should be aware of.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/qudian-full-2024-earnings-eps-100006123.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["QD","CN"],"gpt_icon":0},{"id":"2529684566","title":"Arcus Biosciences to Present First Combination Data for HIF-2a Inhibitor Casdatifan Plus Cabozantinib in an Oral Presentation at the 2025 ASCO Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2529684566","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529684566?lang=en_us&edition=fundamental","pubTime":"2025-04-24 04:05","pubTimestamp":1745438700,"startTime":"0","endTime":"0","summary":"New data from the Phase 1/1b ARC-20 cohort evaluating HIF-2a inhibitor casdatifan in combination with cabozantinib in clear cell renal cell carcinoma  will be presented in an oral session by Dr. Toni Choueiri, Dana-Farber Cancer Institute. The ASCO presentation will include a more mature data cut than that described in the abstract and will include safety and initial efficacy data for the 100mg casdatifan once-daily  plus 60mg cabozantinib QD cohort. Arcus will host a conference call to discuss the ARC-20 data at 5:00 AM PT / 7:00 AM CT on Monday, June 2, 2025. The oral presentation will highlight the first safety and efficacy data for the ARC-20 expansion cohort evaluating the HIF-2a inhibitor casdatifan plus cabozantinib, an anti-vascular endothelial growth factor receptor 2 tyrosine kinase inhibitor , in patients with ccRCC that had previously been treated with immunotherapy alone or in combination with anti-VEGFR2-TKI therapies.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/arcus-biosciences-present-first-combination-200500359.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4503","QD","RCUS","BK4166","BK4139","BK4563"],"gpt_icon":0},{"id":"2529508603","title":"Qudian Files Its Annual Report on Form 20-F","url":"https://stock-news.laohu8.com/highlight/detail?id=2529508603","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529508603?lang=en_us&edition=fundamental","pubTime":"2025-04-23 18:30","pubTimestamp":1745404200,"startTime":"0","endTime":"0","summary":"Qudian will provide a hard copy of the annual report containing its audited consolidated financial statements, free of charge, to its shareholders and ADS holders upon request. Requests should be directed to Investor Relations department, Building 1, Qudian Innovation Park, Meilin Street, Tongan District, Xiamen, Fujian Province, The People's Republic of China, 361000.Qudian is a consumer-oriented technology company. The Company historically focused on providing credit solutions to consumers. Qudian is exploring innovative business opportunities to satisfy consumers' demand by leveraging its technology capabilities.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/qudian-files-annual-report-form-103000363.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/qudian-files-annual-report-form-103000363.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["QD","BK4563","BK4166","BK4503"],"gpt_icon":0},{"id":"2523619086","title":"Mineralys Therapeutics Announces Late-Breaking Data from Advance-HTN Pivotal Trial of Lorundrostat in Uncontrolled and Resistant Hypertension Presented at the American College of Cardiology’s Annual Scientific Session & Expo (ACC.25)","url":"https://stock-news.laohu8.com/highlight/detail?id=2523619086","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523619086?lang=en_us&edition=fundamental","pubTime":"2025-03-30 02:30","pubTimestamp":1743273000,"startTime":"0","endTime":"0","summary":"– Lorundrostat 50 mg dose achieved a 15.4 mmHg absolute reduction and 7.9 mmHg placebo-adjusted reduction , assessed by 24hr ABPM at week 12, with favorable safety and tolerability profile –。– Lorundrostat is a highly selective aldosterone synthase inhibitor that disrupts aldosterone biosynthesis rather than blocking the mineralocorticoid receptor –。– Data from Advance-HTN support the potential of lorundrostat as a best-in-class treatment for high-risk patients with uncontrolled or resistant hypertension who would normally be treated in a specialist setting –。“Twenty-four-hour ambulatory blood pressure monitoring is the gold standard for assessing the true impact of an antihypertensive therapy, as it provides a more comprehensive picture of blood pressure control beyond the office setting, including overnight readings,” stated Luke Laffin, M.D., co-director of the Center for Blood Pressure Disorders in the Heart, Vascular & Thoracic Institute at Cleveland Clinic and the study’s lead au","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/mineralys-therapeutics-announces-breaking-data-183000909.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ARB","BK4117","MLYS","BK4139","LENZ","BK4503","BK4563","AFG","BK4107","QD","BK4166"],"gpt_icon":0},{"id":"2522539232","title":"Press Release: Tyra Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2522539232","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522539232?lang=en_us&edition=fundamental","pubTime":"2025-03-28 04:05","pubTimestamp":1743105900,"startTime":"0","endTime":"0","summary":"- Three INDs cleared by US FDA for TYRA's proprietary precision small molecules -. - TYRA-300 to be evaluated in three Phase 2 studies: SURF302 for Intermediate Risk Non-Muscle Invasive Bladder Cancer , BEACH301 for pediatric achondroplasia  and SURF301 for metastatic urothelial cancer  -. - Cash, cash equivalents, and marketable securities of $341.4 million at YE 2024; runway through at least 2027 -. \"2024 was a momentous year for TYRA and the patient communities we serve, highlighted by the positive interim results from our SURF301 study, which demonstrated a combination of high anti-tumor activity with favorable tolerability results in very sick, heavily pre-treated cancer patients. Importantly, the oncology doses tested in SURF301 are significantly higher than those to be tested in BEACH301, giving us confidence as we advance TYRA-300 in ACH,\" said Todd Harris, CEO of TYRA. \"Our conviction in TYRA-300 has never been stronger and we are working diligently to advance this potential b","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACH","PFS","BK4503","BK4006","BK4153","BK4166","BK4563","CR","BK4139","TYRA","BK4211","BK4195","PR","BK4161","HCC","QD","BK4213"],"gpt_icon":0},{"id":"2522305666","title":"Press Release: InnoCare Releases 2024 Results and Business Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2522305666","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522305666?lang=en_us&edition=fundamental","pubTime":"2025-03-27 21:08","pubTimestamp":1743080880,"startTime":"0","endTime":"0","summary":"InnoCare Pharma , a leading biopharmaceutical company focusing on cancer and autoimmune diseases, today announced the 2024 annual results as of 31 December 2024.-- Revenue of Orelabrutinib increased by 49.1% to RMB 1,000.4 million1 in. 2024, mainly driven by rapid growth of marginal zone lymphoma . indication and strong commercial execution. Total revenue increased by. -- Gross Profit increased by 42.8% to RMB 871.0 million in 2024, with a. gross profit margin of 86.3%, representing an increase of 3.7 percentage. in 2024, primarily due to increased investment in advanced technology. as of 31 December 2024. This robust cash position provides InnoCare with. InnoCare will continue to strengthen the globalization of its other promising pipeline assets. As part of its BD strategy, the Company has been actively exploring collaboration and licensing opportunities for key assets, with a focus on expanding its presence outside of China. The Company remains committed to accelerating the global r","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4563","BK6004","BK4503","BK4097","TLS","BK4166","QD","5I4.SI","ORR","BK6512"],"gpt_icon":0},{"id":"2522837332","title":"New study results reinforce TAGRISSO® (osimertinib) as the backbone therapy for EGFR-mutated lung cancer across stages and settings","url":"https://stock-news.laohu8.com/highlight/detail?id=2522837332","media":"Business Wire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522837332?lang=en_us&edition=fundamental","pubTime":"2025-03-26 07:02","pubTimestamp":1742943720,"startTime":"0","endTime":"0","summary":"SAVANNAH and ORCHARD Phase II trials show the addition of savolitinib or datopotamab deruxtecan-dlnk to TAGRISSO upon disease progression demonstrates strong clinical activity. WILMINGTON, Del., March 25, 2025----New study results presented at the European Lung Cancer Congress  2025, March 26 to 29, demonstrate the role of AstraZeneca’s TAGRISSO , as monotherapy and as the backbone for novel combinations, across stages and settings of epidermal growth factor receptor-mutated  non-small cell lung cancer . Highlights include:. LAURA Phase III trial of TAGRISSO in unresectable, Stage III EGFRm NSCLC after chemoradiotherapy  .SAVANNAH Phase II trial of TAGRISSO plus savolitinib in advanced EGFRm NSCLC with high levels of MET overexpression and/or amplification following disease progression on 1st-line TAGRISSO (#2O).FLAURA2 Phase III trial of TAGRISSO plus chemotherapy as 1st-line treatment for advanced EGFRm NSCLC .Professor Virginia Harrison, EGFR Positive UK, said: \"For people undergoin","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/study-results-reinforce-tagrisso-osimertinib-230200995.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4195","LU1829250122.USD","LU2456880835.USD","BK4231","ORR","BK4563","BK4166","BK4144","BK4568","LU0320765992.SGD","LU0109394709.USD","LU2462157665.USD","BK4585","BK4213","BK4503","LU2236285917.USD","PFS","BK4588","LU2417539215.USD","CRT","BK4124","EMM","BK4080","OS","ADC","BK4007","BK4097","LU0889565916.HKD","TEN","BK4211","QD","AZN"],"gpt_icon":1},{"id":"2522526850","title":"Qudian Inc. Reports Strong 2024 Revenue Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2522526850","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522526850?lang=en_us&edition=fundamental","pubTime":"2025-03-25 11:54","pubTimestamp":1742874888,"startTime":"0","endTime":"0","summary":"Qudian Inc. ( ($QD) ) has released its Q4 earnings. Here is a breakdown of the information Qudian Inc. presented to its investors. Qudian Inc. is a...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/qudian-inc-reports-strong-2024-revenue-growth?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/qudian-inc-reports-strong-2024-revenue-growth?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["QD"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":57,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/QD\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-30","symbol":"QD","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1748577600000,"reportTimeType":"pre","actualEps":0.12},{"market":"US","date":"2025-03-20","symbol":"QD","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1742443200000,"reportTimeType":"pre","actualEps":-0.05},{"market":"US","date":"2024-11-22","symbol":"QD","fiscalQuarterEnding":"2024/09","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1732251600000,"reportTimeType":"pre","actualEps":0.1},{"market":"US","date":"2024-09-06","symbol":"QD","fiscalQuarterEnding":"2024/06","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1725595200000,"reportTimeType":"pre","actualEps":0.07},{"market":"US","date":"2024-06-13","symbol":"QD","fiscalQuarterEnding":"2024/03","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1718251200000,"reportTimeType":"pre","actualEps":-0.05}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"QD\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"QD\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/QD\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"QD","date":"2025-06-05","current":11.226986,"percent":0.737013,"low":-88.607914,"twenty":-4.50361,"median":2.340412,"eighty":18.139904,"high":110.235059,"avg":11.938547,"sd":34.760112,"marketCap":493728211},"quantilePoints":[{"date":"2020-06-12","current":1.494313,"twenty":2.077217,"median":4.820821,"eighty":9.690916,"marketCap":385652934},{"date":"2020-06-19","current":1.697674,"twenty":2.054702,"median":4.802938,"eighty":9.676676,"marketCap":438933932},{"date":"2020-06-26","current":1.709075,"twenty":1.997591,"median":4.760441,"eighty":9.653813,"marketCap":441471122},{"date":"2020-07-02","current":1.68657,"twenty":1.963896,"median":4.75815,"eighty":9.642907,"marketCap":436396741},{"date":"2020-07-10","current":2.312239,"twenty":1.963896,"median":4.748623,"eighty":9.604742,"marketCap":603851305},{"date":"2020-07-17","current":1.97954,"twenty":1.963896,"median":4.718462,"eighty":9.559259,"marketCap":517586833},{"date":"2020-07-24","current":1.616747,"twenty":1.918817,"median":4.713887,"eighty":9.538168,"marketCap":421173599},{"date":"2020-07-31","current":1.568191,"twenty":1.76894,"median":4.700634,"eighty":9.522584,"marketCap":411024838},{"date":"2020-08-07","current":1.614876,"twenty":1.736998,"median":4.673639,"eighty":9.493529,"marketCap":423710790},{"date":"2020-08-14","current":1.755578,"twenty":1.705998,"median":4.644245,"eighty":9.483072,"marketCap":461768645},{"date":"2020-08-21","current":1.622789,"twenty":1.673427,"median":4.641146,"eighty":9.471666,"marketCap":428785170},{"date":"2020-08-28","current":1.591166,"twenty":1.651695,"median":4.639855,"eighty":9.458685,"marketCap":423710790},{"date":"2020-09-04","current":1.471861,"twenty":1.642989,"median":4.637355,"eighty":9.446127,"marketCap":393264505},{"date":"2020-09-11","current":2.9708,"twenty":1.644704,"median":4.630228,"eighty":9.441013,"marketCap":375519436},{"date":"2020-09-18","current":2.763282,"twenty":1.645206,"median":4.617694,"eighty":9.438537,"marketCap":352683795},{"date":"2020-09-25","current":2.544944,"twenty":1.64953,"median":4.600475,"eighty":9.427936,"marketCap":322236273},{"date":"2020-10-02","current":2.612554,"twenty":1.651477,"median":4.596099,"eighty":9.420407,"marketCap":332385447},{"date":"2020-10-09","current":2.75249,"twenty":1.651881,"median":4.578229,"eighty":9.392619,"marketCap":355221088},{"date":"2020-10-16","current":2.537281,"twenty":1.658807,"median":4.56539,"eighty":9.362569,"marketCap":327310860},{"date":"2020-10-23","current":3.004667,"twenty":1.665444,"median":4.549138,"eighty":9.317241,"marketCap":388205903},{"date":"2020-10-30","current":2.632757,"twenty":1.672076,"median":4.545601,"eighty":9.282307,"marketCap":339997327},{"date":"2020-11-06","current":2.718404,"twenty":1.683941,"median":4.537883,"eighty":9.247967,"marketCap":355221088},{"date":"2020-11-13","current":3.007111,"twenty":1.690294,"median":4.530427,"eighty":9.222351,"marketCap":393280490},{"date":"2020-11-20","current":2.891564,"twenty":1.696384,"median":4.514509,"eighty":9.207035,"marketCap":380594023},{"date":"2020-11-27","current":2.781782,"twenty":1.702668,"median":4.503584,"eighty":9.203814,"marketCap":365370262},{"date":"2020-12-04","current":2.64678,"twenty":1.707844,"median":4.491432,"eighty":9.193684,"marketCap":350146501},{"date":"2020-12-11","current":2.557096,"twenty":1.724561,"median":4.482553,"eighty":9.147292,"marketCap":337460034},{"date":"2020-12-18","current":5.102651,"twenty":1.736153,"median":4.48545,"eighty":9.115708,"marketCap":322236273},{"date":"2020-12-24","current":4.937025,"twenty":1.737666,"median":4.491432,"eighty":9.10861,"marketCap":312087099},{"date":"2020-12-31","current":5.537487,"twenty":1.740124,"median":4.502956,"eighty":9.092785,"marketCap":350146501},{"date":"2021-01-08","current":6.444668,"twenty":1.747874,"median":4.514509,"eighty":9.047388,"marketCap":411041545},{"date":"2021-01-15","current":7.208537,"twenty":1.758064,"median":4.530427,"eighty":9.019783,"marketCap":459250121},{"date":"2021-01-22","current":8.445492,"twenty":1.768009,"median":4.537043,"eighty":8.984768,"marketCap":537906219},{"date":"2021-01-29","current":7.942919,"twenty":1.76894,"median":4.542259,"eighty":8.938442,"marketCap":509995991},{"date":"2021-02-05","current":11.924246,"twenty":1.851142,"median":4.548275,"eighty":9.028537,"marketCap":761188047},{"date":"2021-02-12","current":14.445936,"twenty":1.868824,"median":4.559967,"eighty":9.120701,"marketCap":923574830},{"date":"2021-02-19","current":12.380316,"twenty":1.88933,"median":4.571167,"eighty":9.207035,"marketCap":791635568},{"date":"2021-02-26","current":8.51412,"twenty":1.913945,"median":4.592159,"eighty":9.247967,"marketCap":542980806},{"date":"2021-03-05","current":8.703275,"twenty":1.943752,"median":4.599299,"eighty":9.317241,"marketCap":553129980},{"date":"2021-03-12","current":10.400664,"twenty":1.953215,"median":4.601433,"eighty":9.361164,"marketCap":659696307},{"date":"2021-03-19","current":11.042064,"twenty":1.961921,"median":4.622901,"eighty":9.424224,"marketCap":700293003},{"date":"2021-03-26","current":9.04649,"twenty":1.96442,"median":4.63729,"eighty":9.438537,"marketCap":570891035},{"date":"2021-04-01","current":3.967248,"twenty":1.973018,"median":4.623968,"eighty":9.430511,"marketCap":579381903},{"date":"2021-04-09","current":3.769324,"twenty":1.979189,"median":4.609564,"eighty":9.424508,"marketCap":551551331},{"date":"2021-04-16","current":3.234782,"twenty":1.981324,"median":4.600302,"eighty":9.421077,"marketCap":475649772},{"date":"2021-04-23","current":3.274103,"twenty":1.983504,"median":4.594129,"eighty":9.399256,"marketCap":483239928},{"date":"2021-04-30","current":3.503774,"twenty":1.992131,"median":4.576016,"eighty":9.381766,"marketCap":518830805},{"date":"2021-05-07","current":3.345251,"twenty":1.997888,"median":4.559967,"eighty":9.365612,"marketCap":498583750},{"date":"2021-05-14","current":3.211397,"twenty":2.013914,"median":4.548275,"eighty":9.32711,"marketCap":478336694},{"date":"2021-05-21","current":3.515608,"twenty":2.035612,"median":4.542259,"eighty":9.288573,"marketCap":523892569},{"date":"2021-05-28","current":3.479656,"twenty":2.049113,"median":4.537043,"eighty":9.254986,"marketCap":523892569},{"date":"2021-06-04","current":3.679868,"twenty":2.056273,"median":4.530427,"eighty":9.23165,"marketCap":551732271},{"date":"2021-06-11","current":3.563713,"twenty":2.061219,"median":4.514509,"eighty":9.212368,"marketCap":534016097},{"date":"2021-06-18","current":2.275344,"twenty":2.061219,"median":4.502956,"eighty":9.203999,"marketCap":678276370},{"date":"2021-06-25","current":2.191357,"twenty":2.056273,"median":4.491079,"eighty":9.196938,"marketCap":652967550},{"date":"2021-07-02","current":1.87323,"twenty":2.046808,"median":4.479655,"eighty":9.160587,"marketCap":556794035},{"date":"2021-07-09","current":1.730432,"twenty":2.024506,"median":4.46865,"eighty":9.119037,"marketCap":513769041},{"date":"2021-07-16","current":1.662239,"twenty":1.98682,"median":4.463577,"eighty":9.110495,"marketCap":493521986},{"date":"2021-07-23","current":1.586083,"twenty":1.97535,"median":4.450513,"eighty":9.101009,"marketCap":470744048},{"date":"2021-07-30","current":1.53875,"twenty":1.950793,"median":4.445107,"eighty":9.084999,"marketCap":458089638},{"date":"2021-08-06","current":1.552306,"twenty":1.869705,"median":4.442504,"eighty":9.050979,"marketCap":460620520},{"date":"2021-08-13","current":1.363504,"twenty":1.777939,"median":4.417738,"eighty":9.042899,"marketCap":404941116},{"date":"2021-08-20","current":1.283065,"twenty":1.747325,"median":4.38053,"eighty":9.023933,"marketCap":379632297},{"date":"2021-08-27","current":1.300955,"twenty":1.735308,"median":4.371685,"eighty":9.001366,"marketCap":404941116},{"date":"2021-09-03","current":1.403066,"twenty":1.725747,"median":4.364162,"eighty":8.979599,"marketCap":437842582},{"date":"2021-09-10","current":1.335883,"twenty":1.705998,"median":4.3515,"eighty":8.958924,"marketCap":417595526},{"date":"2021-09-17","current":1.340381,"twenty":1.689297,"median":4.343939,"eighty":8.938442,"marketCap":417595526},{"date":"2021-09-24","current":1.23478,"twenty":1.666673,"median":4.335386,"eighty":8.908672,"marketCap":384694060},{"date":"2021-10-01","current":1.206741,"twenty":1.651695,"median":4.321627,"eighty":8.904129,"marketCap":377101415},{"date":"2021-10-08","current":1.319613,"twenty":1.642989,"median":4.309588,"eighty":8.904051,"marketCap":412533762},{"date":"2021-10-15","current":1.261176,"twenty":1.63643,"median":4.279097,"eighty":8.895162,"marketCap":394817588},{"date":"2021-10-22","current":1.475957,"twenty":1.622789,"median":4.248476,"eighty":8.878523,"marketCap":465682284},{"date":"2021-10-29","current":1.343957,"twenty":1.612811,"median":4.241881,"eighty":8.8482,"marketCap":422657290},{"date":"2021-11-05","current":1.334535,"twenty":1.602824,"median":4.216939,"eighty":8.777134,"marketCap":420126408},{"date":"2021-11-12","current":1.386525,"twenty":1.586083,"median":4.210169,"eighty":8.758487,"marketCap":437842582},{"date":"2021-11-19","current":1.219827,"twenty":1.571444,"median":4.181522,"eighty":8.71027,"marketCap":384694060},{"date":"2021-11-26","current":1.172466,"twenty":1.565489,"median":4.172071,"eighty":8.704674,"marketCap":369508769},{"date":"2021-12-03","current":0.993357,"twenty":1.547798,"median":4.150379,"eighty":8.670525,"marketCap":313829365},{"date":"2021-12-10","current":1.12025,"twenty":1.526625,"median":4.120261,"eighty":8.649487,"marketCap":354323477},{"date":"2021-12-17","current":1.090651,"twenty":1.513291,"median":4.096041,"eighty":8.570458,"marketCap":227171966},{"date":"2021-12-23","current":1.226168,"twenty":1.507688,"median":4.064994,"eighty":8.551028,"marketCap":255619079},{"date":"2021-12-31","current":1.173249,"twenty":1.493501,"median":4.041014,"eighty":8.545412,"marketCap":245267772},{"date":"2022-01-07","current":1.23969,"twenty":1.483167,"median":4.018638,"eighty":8.539701,"marketCap":258149961},{"date":"2022-01-14","current":1.283356,"twenty":1.472808,"median":3.996998,"eighty":8.523772,"marketCap":268273489},{"date":"2022-01-21","current":1.141622,"twenty":1.457851,"median":3.988936,"eighty":8.508926,"marketCap":239168347},{"date":"2022-01-28","current":1.053331,"twenty":1.44714,"median":3.979444,"eighty":8.488011,"marketCap":219908335},{"date":"2022-02-04","current":1.162555,"twenty":1.426053,"median":3.967188,"eighty":8.464405,"marketCap":242711581},{"date":"2022-02-11","current":1.199378,"twenty":1.413906,"median":3.942635,"eighty":8.453313,"marketCap":250607933},{"date":"2022-02-18","current":1.097087,"twenty":1.39743,"median":3.939304,"eighty":8.437152,"marketCap":230310260},{"date":"2022-02-25","current":1.008908,"twenty":1.387125,"median":3.918967,"eighty":8.420457,"marketCap":212087909},{"date":"2022-03-04","current":0.908009,"twenty":1.367808,"median":3.907082,"eighty":8.399056,"marketCap":190828501},{"date":"2022-03-11","current":0.869861,"twenty":1.363727,"median":3.88232,"eighty":8.372883,"marketCap":182223502},{"date":"2022-03-18","current":2.787669,"twenty":1.357838,"median":3.876736,"eighty":8.339036,"marketCap":258149961},{"date":"2022-03-25","current":3.336423,"twenty":1.35913,"median":3.866977,"eighty":8.316599,"marketCap":308767601},{"date":"2022-04-01","current":3.389728,"twenty":1.362482,"median":3.852155,"eighty":8.28079,"marketCap":313829365},{"date":"2022-04-08","current":3.444999,"twenty":1.363727,"median":3.83615,"eighty":8.259061,"marketCap":318891129},{"date":"2022-04-14","current":3.013824,"twenty":1.364618,"median":3.815106,"eighty":8.239513,"marketCap":278397017},{"date":"2022-04-22","current":2.765355,"twenty":1.365216,"median":3.792152,"eighty":8.223331,"marketCap":250557316},{"date":"2022-04-29","current":3.058969,"twenty":1.365918,"median":3.769324,"eighty":8.171844,"marketCap":272672787},{"date":"2022-05-06","current":2.828864,"twenty":1.366925,"median":3.715418,"eighty":8.148875,"marketCap":249975302},{"date":"2022-05-13","current":2.211076,"twenty":1.371339,"median":3.703028,"eighty":8.125714,"marketCap":191880850},{"date":"2022-05-20","current":2.2673,"twenty":1.379889,"median":3.673757,"eighty":8.037983,"marketCap":199556084},{"date":"2022-05-27","current":2.096332,"twenty":1.382511,"median":3.648946,"eighty":8.030691,"marketCap":184331853},{"date":"2022-06-03","current":2.359877,"twenty":1.385722,"median":3.622937,"eighty":7.960473,"marketCap":208720919},{"date":"2022-06-10","current":2.330771,"twenty":1.388925,"median":3.617264,"eighty":7.939299,"marketCap":204656075},{"date":"2022-06-17","current":-53.377821,"twenty":1.370456,"median":3.60663,"eighty":7.827996,"marketCap":254999551},{"date":"2022-06-24","current":-57.897972,"twenty":1.364977,"median":3.600751,"eighty":7.800209,"marketCap":277722283},{"date":"2022-07-01","current":-65.908222,"twenty":1.358097,"median":3.577552,"eighty":7.791874,"marketCap":315593503},{"date":"2022-07-08","current":-61.093466,"twenty":1.356202,"median":3.560157,"eighty":7.775858,"marketCap":292870771},{"date":"2022-07-15","current":-63.27086,"twenty":1.346881,"median":3.54788,"eighty":7.722016,"marketCap":300445015},{"date":"2022-07-22","current":-61.624682,"twenty":1.339656,"median":3.542243,"eighty":7.650027,"marketCap":292870771},{"date":"2022-07-29","current":-59.967811,"twenty":1.335074,"median":3.524398,"eighty":7.62701,"marketCap":285296527},{"date":"2022-08-05","current":-59.057527,"twenty":1.329074,"median":3.509691,"eighty":7.610735,"marketCap":280247031},{"date":"2022-08-12","current":-57.299923,"twenty":1.30399,"median":3.480521,"eighty":7.56646,"marketCap":272672787},{"date":"2022-08-19","current":-57.399968,"twenty":1.294829,"median":3.474363,"eighty":7.529188,"marketCap":270148039},{"date":"2022-08-26","current":-55.693437,"twenty":1.28847,"median":3.451858,"eighty":7.459046,"marketCap":260049047},{"date":"2022-09-02","current":-50.865077,"twenty":1.282236,"median":3.439352,"eighty":7.329916,"marketCap":236543642},{"date":"2022-09-09","current":-4.427371,"twenty":1.27284,"median":3.41825,"eighty":7.262178,"marketCap":232276818},{"date":"2022-09-16","current":-4.711862,"twenty":1.26766,"median":3.389728,"eighty":7.055763,"marketCap":244900558},{"date":"2022-09-23","current":-4.507036,"twenty":1.255102,"median":3.334228,"eighty":6.430231,"marketCap":229752070},{"date":"2022-09-30","current":-4.449063,"twenty":1.241844,"median":3.305952,"eighty":6.36321,"marketCap":227227322},{"date":"2022-10-07","current":-4.649044,"twenty":1.233685,"median":3.272439,"eighty":6.315153,"marketCap":237427304},{"date":"2022-10-14","current":-4.397095,"twenty":1.224175,"median":3.258319,"eighty":6.268831,"marketCap":222177826},{"date":"2022-10-21","current":-4.517358,"twenty":1.21703,"median":3.258055,"eighty":6.263868,"marketCap":226697125},{"date":"2022-10-28","current":-4.17876,"twenty":1.21703,"median":3.258055,"eighty":6.263868,"marketCap":209352106},{"date":"2022-11-04","current":-4.316899,"twenty":1.21703,"median":3.258055,"eighty":6.263868,"marketCap":218365457},{"date":"2022-11-11","current":-4.435179,"twenty":1.21703,"median":3.258055,"eighty":6.263868,"marketCap":226747620},{"date":"2022-11-18","current":-4.188263,"twenty":1.206309,"median":3.214152,"eighty":6.038554,"marketCap":213745168},{"date":"2022-11-25","current":-1.441004,"twenty":1.196321,"median":3.183506,"eighty":5.919731,"marketCap":184306606},{"date":"2022-12-02","current":-1.739144,"twenty":1.190341,"median":3.139792,"eighty":5.695609,"marketCap":227227322},{"date":"2022-12-09","current":-1.627951,"twenty":1.184355,"median":3.058969,"eighty":5.613624,"marketCap":214628830},{"date":"2022-12-16","current":-1.787897,"twenty":1.173368,"median":3.004667,"eighty":5.573461,"marketCap":235205526},{"date":"2022-12-23","current":-1.845396,"twenty":1.166568,"median":2.973405,"eighty":5.526558,"marketCap":242224325},{"date":"2022-12-30","current":-1.809474,"twenty":1.152461,"median":2.926816,"eighty":5.501262,"marketCap":240608487},{"date":"2023-01-06","current":-2.145642,"twenty":1.147922,"median":2.899588,"eighty":5.479696,"marketCap":287821275},{"date":"2023-01-13","current":-2.06881,"twenty":1.140337,"median":2.875567,"eighty":5.427519,"marketCap":282771779},{"date":"2023-01-20","current":-2.016512,"twenty":1.137891,"median":2.86131,"eighty":5.392337,"marketCap":272672787},{"date":"2023-01-27","current":-2.259537,"twenty":1.116984,"median":2.824171,"eighty":5.370803,"marketCap":305494511},{"date":"2023-02-03","current":-2.34562,"twenty":1.101853,"median":2.781782,"eighty":5.34608,"marketCap":318118251},{"date":"2023-02-10","current":-2.473528,"twenty":1.090277,"median":2.763282,"eighty":5.316369,"marketCap":333266739},{"date":"2023-02-17","current":-2.533318,"twenty":1.079518,"median":2.732178,"eighty":5.287677,"marketCap":338316236},{"date":"2023-02-24","current":-5.725247,"twenty":1.056339,"median":2.690651,"eighty":5.254644,"marketCap":297920267},{"date":"2023-03-03","current":-5.828855,"twenty":1.037848,"median":2.654874,"eighty":5.22864,"marketCap":305494511},{"date":"2023-03-10","current":-5.456639,"twenty":1.023348,"median":2.647052,"eighty":5.204033,"marketCap":285296527},{"date":"2023-03-17","current":-5.667715,"twenty":1.001884,"median":2.632757,"eighty":5.155718,"marketCap":297920267},{"date":"2023-03-24","current":-5.748207,"twenty":0.988622,"median":2.592496,"eighty":5.123544,"marketCap":302969763},{"date":"2023-03-31","current":-5.74963,"twenty":0.981636,"median":2.560383,"eighty":5.106116,"marketCap":302969763},{"date":"2023-04-06","current":-5.611278,"twenty":0.961891,"median":2.541113,"eighty":5.097377,"marketCap":295395519},{"date":"2023-04-14","current":-5.65364,"twenty":0.948412,"median":2.488418,"eighty":5.048439,"marketCap":297920267},{"date":"2023-04-21","current":-6.231763,"twenty":0.935717,"median":2.439054,"eighty":5.022245,"marketCap":328217243},{"date":"2023-04-28","current":-5.892181,"twenty":0.913999,"median":2.35477,"eighty":4.997161,"marketCap":308019259},{"date":"2023-05-05","current":-5.53935,"twenty":0.906432,"median":2.330771,"eighty":4.985267,"marketCap":290119614},{"date":"2023-05-12","current":-5.396481,"twenty":0.890665,"median":2.309302,"eighty":4.971094,"marketCap":281123657},{"date":"2023-05-19","current":-5.468089,"twenty":0.873834,"median":2.26799,"eighty":4.953015,"marketCap":281123657},{"date":"2023-05-26","current":-5.890594,"twenty":0.84026,"median":2.223866,"eighty":4.941783,"marketCap":301364560},{"date":"2023-06-02","current":-6.08478,"twenty":0.822461,"median":2.20614,"eighty":4.930121,"marketCap":310360517},{"date":"2023-06-09","current":-7.997073,"twenty":0.753762,"median":2.191357,"eighty":4.862414,"marketCap":407067056},{"date":"2023-06-16","current":14.961744,"twenty":0.730045,"median":2.189117,"eighty":4.854051,"marketCap":409316045},{"date":"2023-06-23","current":16.549358,"twenty":0.725764,"median":2.188964,"eighty":4.847095,"marketCap":449797852},{"date":"2023-06-30","current":16.548854,"twenty":0.721483,"median":2.188811,"eighty":4.838592,"marketCap":445299873},{"date":"2023-07-07","current":16.798434,"twenty":0.721483,"median":2.188811,"eighty":4.838592,"marketCap":452046841},{"date":"2023-07-14","current":18.049358,"twenty":0.721483,"median":2.188811,"eighty":4.838592,"marketCap":492528647},{"date":"2023-07-21","current":17.617452,"twenty":0.721483,"median":2.188811,"eighty":4.838592,"marketCap":479034712},{"date":"2023-07-28","current":18.520305,"twenty":0.721483,"median":2.188811,"eighty":4.838592,"marketCap":503773594},{"date":"2023-08-04","current":19.822164,"twenty":0.721483,"median":2.188811,"eighty":4.838592,"marketCap":539757422},{"date":"2023-08-11","current":20.546635,"twenty":0.721483,"median":2.188811,"eighty":4.838592,"marketCap":555500347},{"date":"2023-08-18","current":18.151135,"twenty":0.721483,"median":2.188811,"eighty":4.838592,"marketCap":485781680},{"date":"2023-08-25","current":19.54183,"twenty":0.721483,"median":2.188811,"eighty":4.838592,"marketCap":524014497},{"date":"2023-09-01","current":21.080767,"twenty":0.721483,"median":2.188811,"eighty":4.838592,"marketCap":566745293},{"date":"2023-09-08","current":17.988448,"twenty":0.721483,"median":2.188811,"eighty":4.838592,"marketCap":440801894},{"date":"2023-09-15","current":18.317701,"twenty":0.721483,"median":2.188811,"eighty":4.838592,"marketCap":452046841},{"date":"2023-09-22","current":18.211445,"twenty":0.721483,"median":2.188811,"eighty":4.838592,"marketCap":447548862},{"date":"2023-09-29","current":19.475841,"twenty":0.721483,"median":2.188811,"eighty":4.838592,"marketCap":479034712},{"date":"2023-10-06","current":18.743843,"twenty":0.721483,"median":2.188811,"eighty":4.838592,"marketCap":461042798},{"date":"2023-10-13","current":18.65139,"twenty":0.721483,"median":2.188811,"eighty":4.867143,"marketCap":458793809},{"date":"2023-10-20","current":17.497268,"twenty":0.721483,"median":2.188811,"eighty":4.934175,"marketCap":429556948},{"date":"2023-10-27","current":16.217847,"twenty":-0.124554,"median":2.185731,"eighty":4.941783,"marketCap":398071099},{"date":"2023-11-03","current":15.850472,"twenty":-0.124554,"median":2.185731,"eighty":4.959403,"marketCap":389075141},{"date":"2023-11-10","current":15.688202,"twenty":-0.124554,"median":2.185731,"eighty":4.984734,"marketCap":386826152},{"date":"2023-11-17","current":15.779975,"twenty":-0.124554,"median":2.185731,"eighty":5.009021,"marketCap":391324131},{"date":"2023-11-24","current":14.407243,"twenty":-0.124554,"median":2.185731,"eighty":5.031648,"marketCap":362087270},{"date":"2023-12-01","current":14.119989,"twenty":-0.124554,"median":2.185731,"eighty":5.061029,"marketCap":355340303},{"date":"2023-12-08","current":16.375706,"twenty":0.296324,"median":2.187935,"eighty":5.102649,"marketCap":411565034},{"date":"2023-12-15","current":5.13977,"twenty":0.296324,"median":2.187935,"eighty":5.09701,"marketCap":467789766},{"date":"2023-12-22","current":5.193137,"twenty":0.296324,"median":2.187935,"eighty":5.09701,"marketCap":470038755},{"date":"2023-12-29","current":5.167392,"twenty":-0.124554,"median":2.185731,"eighty":5.105888,"marketCap":470038755},{"date":"2024-01-05","current":5.271514,"twenty":-0.545433,"median":2.183526,"eighty":5.117907,"marketCap":476785723},{"date":"2024-01-12","current":5.442904,"twenty":-0.545433,"median":2.183526,"eighty":5.148286,"marketCap":492528647},{"date":"2024-01-19","current":5.433825,"twenty":-0.966311,"median":2.182901,"eighty":5.16623,"marketCap":488030669},{"date":"2024-01-26","current":5.069182,"twenty":-0.545433,"median":2.183526,"eighty":5.152858,"marketCap":458793809},{"date":"2024-02-02","current":5.346932,"twenty":-0.545433,"median":2.183526,"eighty":5.165068,"marketCap":481283701},{"date":"2024-02-09","current":5.478707,"twenty":-0.545433,"median":2.183526,"eighty":5.198595,"marketCap":494777637},{"date":"2024-02-16","current":6.309669,"twenty":-0.545433,"median":2.183526,"eighty":5.238229,"marketCap":568994282},{"date":"2024-02-23","current":6.132491,"twenty":-0.545433,"median":2.183526,"eighty":5.278851,"marketCap":551002368},{"date":"2024-03-01","current":6.129507,"twenty":-0.124554,"median":2.185731,"eighty":5.28407,"marketCap":551002368},{"date":"2024-03-08","current":5.831557,"twenty":-0.124554,"median":2.185731,"eighty":5.293518,"marketCap":524014497},{"date":"2024-03-15","current":6.107883,"twenty":-0.124554,"median":2.185731,"eighty":5.315877,"marketCap":548753379},{"date":"2024-03-22","current":103.435233,"twenty":-0.124554,"median":2.185731,"eighty":5.348813,"marketCap":562247315},{"date":"2024-03-28","current":103.41931,"twenty":-0.124554,"median":2.185731,"eighty":5.36835,"marketCap":559998325},{"date":"2024-04-05","current":99.779196,"twenty":-0.545433,"median":2.183526,"eighty":5.384537,"marketCap":539757422},{"date":"2024-04-12","current":101.071124,"twenty":-0.545433,"median":2.183526,"eighty":5.402533,"marketCap":546504390},{"date":"2024-04-19","current":93.598599,"twenty":-0.545433,"median":2.183526,"eighty":5.433865,"marketCap":506022583},{"date":"2024-04-26","current":101.175863,"twenty":-0.124554,"median":2.185731,"eighty":5.454663,"marketCap":546504390},{"date":"2024-05-03","current":100.260037,"twenty":-0.124554,"median":2.185731,"eighty":5.479265,"marketCap":542006411},{"date":"2024-05-10","current":79.679719,"twenty":-0.124554,"median":2.185731,"eighty":5.479265,"marketCap":431840780},{"date":"2024-05-17","current":68.485221,"twenty":-0.124554,"median":2.185731,"eighty":5.504513,"marketCap":371231547},{"date":"2024-05-24","current":60.287412,"twenty":-0.124554,"median":2.185731,"eighty":5.616715,"marketCap":325774623},{"date":"2024-05-31","current":59.936079,"twenty":-0.124554,"median":2.185731,"eighty":5.781947,"marketCap":323880585},{"date":"2024-06-07","current":57.857018,"twenty":-0.124554,"median":2.185731,"eighty":5.86056,"marketCap":312516354},{"date":"2024-06-14","current":-5.111058,"twenty":-1.39972,"median":2.182277,"eighty":5.972137,"marketCap":316304431},{"date":"2024-06-21","current":-5.791635,"twenty":-1.513498,"median":2.164796,"eighty":5.975765,"marketCap":357973278},{"date":"2024-06-28","current":-5.736583,"twenty":-1.56144,"median":2.157614,"eighty":5.995678,"marketCap":354185201},{"date":"2024-07-05","current":-5.737924,"twenty":-1.647893,"median":2.11897,"eighty":5.995678,"marketCap":354185201},{"date":"2024-07-12","current":-5.544422,"twenty":-1.785668,"median":2.096332,"eighty":5.995678,"marketCap":342820970},{"date":"2024-07-15","current":-5.480589,"twenty":-1.788185,"median":2.092657,"eighty":5.995678,"marketCap":339032893},{"date":"2024-08-02","current":-5.440877,"twenty":-1.799974,"median":2.061277,"eighty":6.054033,"marketCap":337138854},{"date":"2024-08-09","current":-5.117277,"twenty":-1.845396,"median":2.034008,"eighty":6.054033,"marketCap":320092508},{"date":"2024-08-16","current":-5.450277,"twenty":-1.902036,"median":1.990803,"eighty":6.054033,"marketCap":340926931},{"date":"2024-08-23","current":-5.548409,"twenty":-2.06444,"median":1.969537,"eighty":6.054033,"marketCap":348503085},{"date":"2024-08-30","current":-5.422274,"twenty":-2.132648,"median":1.906636,"eighty":6.054033,"marketCap":342820970},{"date":"2024-09-06","current":-5.507717,"twenty":-2.192208,"median":1.858821,"eighty":6.054033,"marketCap":348503085},{"date":"2024-09-13","current":-9.164942,"twenty":-2.305525,"median":1.754206,"eighty":6.054033,"marketCap":350397124},{"date":"2024-09-20","current":-9.248138,"twenty":-2.4266,"median":1.735942,"eighty":6.054033,"marketCap":356079239},{"date":"2024-09-27","current":-9.857249,"twenty":-2.554208,"median":1.725079,"eighty":6.054033,"marketCap":382595779},{"date":"2024-10-04","current":-10.767472,"twenty":-4.167739,"median":1.694449,"eighty":6.054033,"marketCap":416688472},{"date":"2024-10-11","current":-10.349658,"twenty":-4.226527,"median":1.67005,"eighty":6.054033,"marketCap":397748087},{"date":"2024-10-18","current":-10.261164,"twenty":-4.307673,"median":1.65115,"eighty":6.054033,"marketCap":392065971},{"date":"2024-10-25","current":-11.347424,"twenty":-4.342601,"median":1.641046,"eighty":6.054033,"marketCap":433734818},{"date":"2024-10-31","current":-11.642279,"twenty":-4.424771,"median":1.629603,"eighty":6.054033,"marketCap":445099049},{"date":"2024-11-08","current":-11.890684,"twenty":-4.437526,"median":1.614876,"eighty":6.064803,"marketCap":452675203},{"date":"2024-11-15","current":-11.580432,"twenty":-4.453178,"median":1.602824,"eighty":6.064803,"marketCap":435628857},{"date":"2024-11-22","current":-12.242757,"twenty":-4.500185,"median":1.585373,"eighty":6.064803,"marketCap":460251357},{"date":"2024-11-29","current":105.02825,"twenty":-4.500185,"median":1.585373,"eighty":6.132491,"marketCap":594728092},{"date":"2024-12-06","current":101.226386,"twenty":-4.500185,"median":1.585373,"eighty":6.322232,"marketCap":571999630},{"date":"2024-12-13","current":98.989053,"twenty":-4.500185,"median":1.585373,"eighty":7.397105,"marketCap":558741360},{"date":"2024-12-20","current":85.236807,"twenty":-4.500185,"median":1.585373,"eighty":8.248611,"marketCap":479191743},{"date":"2024-12-27","current":98.062015,"twenty":-4.500185,"median":1.585373,"eighty":8.459218,"marketCap":551165206},{"date":"2025-01-03","current":94.372016,"twenty":-4.500185,"median":1.585373,"eighty":8.718047,"marketCap":530330782},{"date":"2025-01-10","current":92.424911,"twenty":-4.501898,"median":1.584133,"eighty":8.928773,"marketCap":517072513},{"date":"2025-01-17","current":91.747806,"twenty":-4.501898,"median":1.584488,"eighty":9.39695,"marketCap":513284436},{"date":"2025-01-24","current":98.596639,"twenty":-4.501898,"median":1.601225,"eighty":9.783586,"marketCap":554953283},{"date":"2025-01-31","current":99.438002,"twenty":-4.501898,"median":1.613843,"eighty":10.562535,"marketCap":562529437},{"date":"2025-02-07","current":99.950895,"twenty":-4.501898,"median":1.625636,"eighty":11.383302,"marketCap":562529437},{"date":"2025-02-14","current":100.350725,"twenty":-4.501898,"median":1.641046,"eighty":12.297388,"marketCap":564423475},{"date":"2025-02-21","current":107.205077,"twenty":-4.501898,"median":1.647915,"eighty":12.677797,"marketCap":606092323},{"date":"2025-02-28","current":94.118612,"twenty":-4.501898,"median":1.664456,"eighty":14.155737,"marketCap":530330782},{"date":"2025-03-07","current":91.684274,"twenty":-4.50361,"median":1.691225,"eighty":14.495249,"marketCap":518966551},{"date":"2025-03-14","current":90.651653,"twenty":-4.50361,"median":1.724908,"eighty":15.427996,"marketCap":513284436},{"date":"2025-03-21","current":96.715498,"twenty":-4.50361,"median":1.734885,"eighty":15.679813,"marketCap":547377129},{"date":"2025-03-28","current":89.912948,"twenty":-4.50361,"median":1.752834,"eighty":15.814795,"marketCap":507602320},{"date":"2025-04-04","current":88.086277,"twenty":-4.50361,"median":1.851142,"eighty":15.971694,"marketCap":496238089},{"date":"2025-04-11","current":77.337205,"twenty":-4.501898,"median":1.906636,"eighty":16.218055,"marketCap":433734818},{"date":"2025-04-17","current":82.909148,"twenty":-4.501898,"median":1.979101,"eighty":16.305595,"marketCap":465933473},{"date":"2025-04-25","current":39.881609,"twenty":-4.50361,"median":2.047379,"eighty":16.523356,"marketCap":501920205},{"date":"2025-05-02","current":34.424887,"twenty":-4.50361,"median":2.096332,"eighty":16.652628,"marketCap":434282673},{"date":"2025-05-09","current":37.644985,"twenty":-4.50361,"median":2.171494,"eighty":16.949627,"marketCap":477215561},{"date":"2025-05-16","current":36.589006,"twenty":-4.50361,"median":2.211076,"eighty":17.3005,"marketCap":465656707},{"date":"2025-05-23","current":35.92929,"twenty":-4.50361,"median":2.275344,"eighty":18.019236,"marketCap":457400382},{"date":"2025-05-30","current":38.287723,"twenty":-4.50361,"median":2.313373,"eighty":18.139904,"marketCap":488774416},{"date":"2025-06-05","current":11.226986,"twenty":-4.50361,"median":2.340412,"eighty":18.139904,"marketCap":493728211}],"updateTime":1749214102275}}}